MedPharm Ltd, a contract developer of topical and transdermal pharmaceutical products, is opening a new location in Raleigh-Durham, NC that will expand its CDMO services in topical and transdermal delivery.
 
Doubling its existing footprint, the facility will support process development, clinical and small-scale commercial manufacturing for semi-solid and liquid pharmaceutical products.
 
This new site, located within a few miles of MedPharm’s current Center of Excellence for topical and transdermal development, gives MedPharm’s clients the opportunity to manufacture clinical batches and commercial scale products in the U.S.
 
“MedPharm’s investment in this facility is a clear demonstration of our continued commitment to a global vision by expanding client services downstream into commercial manufacturing,” said Eugene Ciolfi, MedPharm’s president and CEO. “MedPharm’s newest facility is an extension of our development services and will also support our client base with their clinical and commercial pipelines needs for topical and transdermal products globally.”
 
The facility is designed to meet all FDA, EMA and GMP requirements with state-of-the art design, operational support systems, technology and resource management.

For more information click here.